Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

ClinicalTrials.gov ID: NCT07682597

Public ClinicalTrials.gov record NCT07682597. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.

Study identification

NCT ID
NCT07682597
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Timothy Mullett
Other
Enrollment
200 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2026
Primary completion
Jun 30, 2028
Completion
Jun 30, 2029
Last update posted
Jul 5, 2026

2026 – 2029

United States locations

U.S. sites
13
U.S. states
2
U.S. cities
12
Facility City State ZIP Site status
Delta Health System Greenville Mississippi 38703 Recruiting
Greenwood Leflore Hospital Greenwood Mississippi 38930 Recruiting
Memorial Hospital Gulfport Gulfport Mississippi 39501 Recruiting
Hattiesburg Clinic Hattiesburg Mississippi 39401 Recruiting
University of Mississippi Medical Center Jackson Mississippi 39216 Recruiting
Baptist Memorial Hospital New Albany Mississippi 38652 Recruiting
North Mississippi Health Services Tupelo Mississippi 38801 Recruiting
Mt. Grant General Hospital Hawthorne Nevada 89415 Recruiting
Desert View Hospital Pahrump Nevada 89048 Recruiting
Renown Regional Medical Center Reno Nevada 89502 Recruiting
Sierra Medical Center Reno Nevada 89511 Recruiting
Sunrise Health Winchester Nevada 89109 Recruiting
Humboldt General Hospital Winnemucca Nevada 89445 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07682597, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07682597 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →